We expect medical margin in the range of $138,000,000 to $148,000,000 representing 74% growth And adjusted EBITDA of $2,000,000 to $10,000,000 compared to negative $3,000,000 in the prior year. Our adjusted EBITDA outlook The Q2 now includes $19,000,000 to $16,000,000 in geographic entry costs. For the full year 2023, we expect total membership live on the Agilon platform will grow to 490,000 to 500,000 members. This includes higher MA membership outlook of 405,000 to 410,000 representing growth of approximately 51% at the midpoint And ACO Reach membership unchanged at 85,000 to 90,000 members. Revenue growth is now expected to increase 63% at the midpoint to a range of 4 $41,000,000 to $4,440,000,000 We anticipate medical margin in a range of $535,000,000 to $560,000,000 And adjusted EBITDA in a range of negative $3,000,000 to positive $25,000,000 Our adjusted EBITDA outlook for the full year 2023 now includes $78,000,000 to $65,000,000 in geography entry costs.